Haren Rupani - Global Head of Oncology Clinical Imaging Novartis

On the advantages of exploratory imaging for early drug response and will the economic downturn impact the goal of right patient, right medicine, right dose?

The global financial crisis is impacting many different sectors of the pharmaceutical industry, including the clinical imaging space.

Will this impact how imaging techniques applied to oncology can aid the monitoring of cancer?

In this interview, Haren talks with Adam Burns about:

The advantages of exploratory imaging for early drug response
The challenges of imaging in multi-center, multi-region trials
Right patient, right medicine, right dose: imaging and the economic downturn
Imaging and the monitoring of cancer

Category:

People & Blogs

Tags:

• Exploratory Imaging
• Pharmaceutical Industry
• Clinical Imaging Space
• Oncology
• Novartis
• MeettheBoss